Visibly Becomes First FDA-Cleared Online Vision Test in the United States
Visibly has announced that, as of August 12, 2022, it has received 510(k) Clearance from the United States Food and Drug Administration for its Visibly Digital Acuity Product (VDAP). Visibly becomes the first FDA-cleared online visual acuity test on the US market.
Consumers can access Visibly's on-demand, self-administered visual acuity test using a combination of a touchscreen mobile device and computer connected to the internet. Consumers can take the test at any time and complete the entire experience in about 6 minutes. Completed vision test results are made available to Eye Care Professionals immediately and securely.
Read more about the clearance here.
New machine-learning approach could speed precision drug development
The approach, detailed this week in the journal Nature, uses a platform called Molecular Surface Interaction Fingerprinting (MaSIF) to design custom proteins that bind to drug-bound target proteins.
AI-enabled CGM app shows promise for glycemic control, weight management
The broader implications of this study suggest that digital health platforms like January V2 have the potential to play a crucial role in the future of chronic disease management,” the authors write.
